E-DRUG: Fexofenadine to replace terfenadine (cont'd)

e-drug
1

E-drug: Fexofenadine to replace terfenadine (cont'd)
------------------------------------------------------

Pharmacologically and medically the replacement makes sense. Are there
cost implications? Will the branded and generic replacement products
[in the US, and in other countries] be sold in equivalent dosages, the
same pack sizes, at the same prices? There are several other effective
"non-sedating" antihistamines, so how is the substitution likely to
affect the choice hierarchy? How should it do so?

Andrew Herxheimer
Emeritus Fellow, UK Cochrane Centre
9 Park Crescent
London N3 2NL, UK
phone: +44 181 346 5470
fax: +44 181 346 0407
e-mail: Andrew_Herxheimer@compuserve.com
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.